{"id":"W2525975938","doi":"10.1200/jco.2016.34.15_suppl.6091","title":"Pembrolizumab for advanced papillary or follicular thyroid cancer: preliminary results from the phase 1b KEYNOTE-028 study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Papillary thyroid cancer; Thyroid cancer; Lenvatinib; Internal medicine; Follicular thyroid cancer; Cancer; Follicular phase; Oncology; Thyroid carcinoma; Thyroid; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002857745,0.0009347617,0.0009920393,0.000257879,0.0003226342,0.0007585887,0.0007878356,0.001303458,0.004791205],"category_scores_gemma":[0.001136859,0.0004483408,0.0009081837,0.0003586744,0.0004831559,0.0007231843,0.0004118365,0.001868684,0.001309877],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00088651,"about_ca_system_score_gemma":0.001400615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001189014,"about_ca_topic_score_gemma":0.003456927,"domain_scores_codex":[0.9995276,0.0002385673,0.00002660366,0.00005940619,0.00005923664,0.00008866213],"domain_scores_gemma":[0.9994111,0.0001109273,0.0001372829,0.00004481961,0.00005020372,0.0002457628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6280226,0.04302293,0.01817995,0.003182414,0.003276004,0.0006227247,0.0004119747,0.003242648,0.05278634,0.0005067114,0.0347196,0.2120261],"study_design_scores_gemma":[0.7434318,0.2051262,0.03049307,0.0001638989,0.001421703,0.0007371817,0.00008046098,0.001549927,0.002863458,0.0003693562,0.0137246,0.00003824815],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9609523,0.01427335,0.001410838,0.00188531,0.0002368944,0.005873454,0.008873021,0.0002326126,0.006262273],"genre_scores_gemma":[0.9641151,0.006591464,0.003226702,0.003409751,0.0002724235,0.004951117,0.01235075,0.00005995038,0.005022814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004791205,"threshold_uncertainty_score":0.01602817,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1397906944189803,"score_gpt":0.4986722398466031,"score_spread":0.3588815454276229,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}